ATC code L01
Abemaciclib
Ablation
Acetaminophen
Aclarubicin
Adagrasib
Adenine
Adenosine deaminase inhibitor
Aflibercept
Albumin
Alitretinoin
Alkyl sulfonate
Alkyl sulfonates
Alkylating agent
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antiemetic
Antiemetics
Antifolate
Antimetabolite
Antineoplastic
Aplasia
Apoptosis
Area under the curve
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Belinostat
Belotecan
Belzutifan
Bendamustine
Benzodiazepine
Bexarotene
Bibcode (identifier)
Bilirubin
Bioavailability
Biological half-life
Bisantrene
Bleomycin
Bone marrow
Bone marrow transplantation
Bortezomib
Boxed warning
Brexucabtagene autoleucel
Busulfan (data page)
CAS Registry Number
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carcinogen
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chemotherapy drug
Chlorambucil
Chlormethine
Chronic myelogenous leukemia
Chronic myeloid leukemia
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclodextrin
Cyclophosphamide
Cytarabine
DNA
DNA crosslinking
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
DailyMed
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dicycloplatin
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug metabolism
Drug nomenclature
Drugs.com
Duvelisib
ECHA InfoCard
Edema
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Emesis
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Medicines Agency
Exatecan
Excretion
FDA
Farnesyltransferase inhibitor
Film coating
First order kinetics
Floxuridine
Fludarabine
Fluorouracil
Food and Drug Administration
Fotemustine
Fuzuloparib
Gemcitabine
Gimatecan
Glasdegib
GlaxoSmithKline
Glutathione
Gold standard (test)
Guanine
Guide to Pharmacology
Halogenation
Hepatomegaly
Histone deacetylase inhibitor
Hydrazine
Hydroxycarbamide
Hyperpigmentation
Hypomethylating agent
IMP dehydrogenase
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imatinib
Imetelstat
Inavolisib
Intercalation (biochemistry)
International Agency for Research on Cancer
International Chemical Identifier
Interstrand crosslinks
Intravenous therapy
Irinotecan
Isocitrate dehydrogenase
Itraconazole
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Larotaxel
Leukemias
Levetiracetam
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Liver
Lomustine
Lonidamine
Losoxantrone
Lucanthone
Lurbinectedin
Lurtotecan
Lymphomas
M phase
Mannosulfan
Masoprocol
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Mesylate
Metabolites
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitosan
Mitosene
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
Myeloproliferative disorders
Nadofaragene firadenovec
Nausea
Navitoclax
Nedaplatin
Nelarabine
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Nucleophilic
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Oral administration
Ortataxel
Otsuka Pharmaceutical
Oxaliplatin
PARP inhibitor
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacokinetics
Phases of clinical research
Phenytoin
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Plasma protein binding
Platelet
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Pregnancy category
Prescription drug
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Pulmonary fibrosis
Purine analogue
Pyrimidine analogue
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Romidepsin
Route of administration
Rubitecan
Rucaparib
S2CID (identifier)
SN2
S phase
Satraplatin
Seizures
Seliciclib
Selinexor
Semustine
Serotonin
Sex steroid
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Sotorasib
Spindle poison
Standard for the Uniform Scheduling of Medicines and Poisons
Streptomyces
Streptozotocin
Sulfonate
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Therapeutic drug monitoring
Thiopurine
Thiotepa
Thrombocytopenia
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
U.S. Food and Drug Administration
Umbralisib
Unique Ingredient Identifier
Uramustine
Ursodiol
Valrubicin
Veliparib
Venetoclax
Veno-occlusive disease
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vomiting
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
Wasting syndrome
Zorubicin